This Solicitation opportunity from Department Of Defense was posted on June 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SUMATRIPTAN SUCCINA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract pertains to the procurement of Sumatriptan Succinate, identified by the National Stock Number (NSN) 6505-01-724-6289, with a specified quantity of 9 units. The solicitation was issued by the Defense Logistics Agency, a department within the U.S. Department of Defense, as part of a federal acquisition. The solicitation, numbered SPE2DP-26-T-3649, was posted on June 3, 2026, with a response deadline set for June 9, 2026, indicating a short response window for interested parties. The contract process is conducted through a solicitation mechanism without any specified set-aside type or NAICS code requirements, suggesting it is open to all qualified bidders. The place of performance and office address details are not specified, but the procurement is managed within the U.S. government framework. The contract documentation and bidding details are accessible via the Defense Logistics Agency’s electronic procurement system, facilitating supplier participation in the acquisition of this pharmaceutical product.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
